ATOSSA THERAPEUTICS Trademark

Trademark Overview


On Friday, November 15, 2024, a trademark application was filed for ATOSSA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ATOSSA THERAPEUTICS trademark a serial number of 98855971. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, May 27, 2025. This trademark is owned by Atossa Therapeutics, Inc.. The ATOSSA THERAPEUTICS trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Biological preparations for the treatment of breast cancer; Pharmaceutical preparations for the treatment of breast cancer; Medicinal preparations for the treatment of breast cancer

Medical diagnosis and treatment of breast cancer
atossa therapeutics

General Information


Serial Number98855971
Word MarkATOSSA THERAPEUTICS
Filing DateFriday, November 15, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, May 27, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 17, 2025

Trademark Statements


Description of MarkThe mark consists of the wording "ATOSSA THERAPEUTICS" next to a drawing of partial face.
Goods and ServicesBiological preparations for the treatment of breast cancer; Pharmaceutical preparations for the treatment of breast cancer; Medicinal preparations for the treatment of breast cancer
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesMedical diagnosis and treatment of breast cancer
NOT AVAILABLE"THERAPEUTICS"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 15, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, November 15, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAtossa Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98125

Trademark Events


Event DateEvent Description
Friday, November 15, 2024NEW APPLICATION ENTERED
Friday, January 17, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, January 17, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, January 17, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 27, 2025WITHDRAWAL OF ATTORNEY GRANTED
Monday, January 27, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Thursday, February 13, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 13, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, February 13, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 13, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 13, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, May 8, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, May 8, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 12, 2025ASSIGNED TO EXAMINER
Wednesday, May 14, 2025EXAMINERS AMENDMENT -WRITTEN
Wednesday, May 14, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, May 14, 2025EXAMINERS AMENDMENT E-MAILED
Wednesday, May 14, 2025EXAMINER'S AMENDMENT ENTERED
Wednesday, May 14, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 11, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED